1192172-68-1 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 5-bromo-4-methylbenzofuran-2-carboxylate is used as a key intermediate in the synthesis of various pharmaceuticals and bioactive molecules. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Anticancer Research:
Ethyl 5-bromo-4-methylbenzofuran-2-carboxylate is used as a potential anticancer agent. Its structure and properties have been studied for their ability to target and inhibit the growth of cancer cells, making it a promising candidate for further research and development in oncology.
Used in Antiviral Research:
Ethyl 5-bromo-4-methylbenzofuran-2-carboxylate is used as a potential antiviral agent. Its unique structure and properties have been investigated for their ability to inhibit viral replication and infectivity, offering potential applications in the development of new antiviral therapies.
Used in Central Nervous System Research:
Ethyl 5-bromo-4-methylbenzofuran-2-carboxylate is used in the study of its activity in the central nervous system. Its potential neuroprotective and neuromodulatory effects are being explored for the development of new treatments for neurological disorders and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1192172-68-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,2,1,7 and 2 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1192172-68:
(9*1)+(8*1)+(7*9)+(6*2)+(5*1)+(4*7)+(3*2)+(2*6)+(1*8)=151
151 % 10 = 1
So 1192172-68-1 is a valid CAS Registry Number.
1192172-68-1Relevant academic research and scientific papers
FXR receptor agonist
-
, (2019/02/10)
The present invention discloses an FXR receptor agonist, belongs to the technical field of medicine, and particularly relates to a compound represented by a formula (I), a pharmaceutically acceptablesalt, an ester or a stereoisomer thereof, wherein R, R, R, M, L, L1, W, A , B, Q, m and n are defined in the specification. The present invention further relates to a preparation method of the compound, a pharmaceutical preparation, and applications in preparation of drugs for treatment and/or prevention of nonalcoholic fatty liver disease, primary biliary cirrhosis, lipid metabolism disorder, diabetic complication, malignant tumors and other related diseases mediated by FXR receptors. The formula I is defined in the specification.
Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulators
-
Page/Page column 27-28, (2009/10/31)
The present invention relates to compounds of formula (I) wherein the substituents are as defined in the claims, including pharmaceutical compositions thereof and for their use in the treatment and/or prevention and/or amelioration of one or more symptoms
